Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center

Smoking is a risk factor for developing bladder cancer (BCa). Even though continued exposure after diagnosis may adversely affect prognosis, patients may be reluctant to disclose to their physicians that they are currently smoking, leading to inaccurate reporting of exposure and missed opportunities...

Full description

Saved in:
Bibliographic Details
Published in:European urology focus 2016-10, Vol.2 (4), p.441
Main Authors: Thong, Alan E, Petruzella, Stacey, Orlow, Irene, Zabor, Emily C, Ehdaie, Behfar, Ostroff, Jamie S, Bochner, Bernard H, Furberg Barnes, Helena
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page 441
container_title European urology focus
container_volume 2
creator Thong, Alan E
Petruzella, Stacey
Orlow, Irene
Zabor, Emily C
Ehdaie, Behfar
Ostroff, Jamie S
Bochner, Bernard H
Furberg Barnes, Helena
description Smoking is a risk factor for developing bladder cancer (BCa). Even though continued exposure after diagnosis may adversely affect prognosis, patients may be reluctant to disclose to their physicians that they are currently smoking, leading to inaccurate reporting of exposure and missed opportunities to deliver smoking-cessation advice and treatment in the context of cancer care. We examined the extent of misclassification of recent smoking exposure among patients undergoing BCa surveillance. A consecutive sample of 145 patients with a self-reported smoking history and prior initial diagnosis of BCa was recruited from a tertiary referral urology clinic. Patients were asked if they had smoked a cigarette or used nicotine replacement therapy (NRT) within the past week and whether they lived with a smoker. At the same visit, we collected urine under a biospecimen protocol. We used urinary cotinine, the primary metabolite of nicotine, as an objective biomarker of recent smoking exposure. Nine patients whose urine could not be interpreted for cotinine were excluded. We calculated the smoking status misreporting rate by comparing biochemically verified smoking status (≥31.5 ng/ml vs
doi_str_mv 10.1016/j.euf.2015.12.002
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_28723477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>28723477</sourcerecordid><originalsourceid>FETCH-pubmed_primary_287234773</originalsourceid><addsrcrecordid>eNqFjr1OwzAUhS0k1FbQB-iC7gvE2E7SlLFERYyIlLkyyXXl4sTRjY3owrPjSjAzHZ2fTzqMraTgUsj1_YljNFwJWXKpuBDqii1UIcqsKNcPc7acppMQqS2qfJPP2FxtKpUXVbVg39u2jaTbM3gDDTqTEY6eAnbQ9P7DDkfYfY1-ioSw7X2yj053HRLUemiTvOhgcQgTvA0pPfoL0UT6ROvcZQE6gIY9UrCazvCKBom0gzpBSLfs2mg34fJXb9jd025fP2djfO-xO4xk-4Qd_g7n_w5-AMOWU6k</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center</title><source>ScienceDirect Journals</source><creator>Thong, Alan E ; Petruzella, Stacey ; Orlow, Irene ; Zabor, Emily C ; Ehdaie, Behfar ; Ostroff, Jamie S ; Bochner, Bernard H ; Furberg Barnes, Helena</creator><creatorcontrib>Thong, Alan E ; Petruzella, Stacey ; Orlow, Irene ; Zabor, Emily C ; Ehdaie, Behfar ; Ostroff, Jamie S ; Bochner, Bernard H ; Furberg Barnes, Helena</creatorcontrib><description>Smoking is a risk factor for developing bladder cancer (BCa). Even though continued exposure after diagnosis may adversely affect prognosis, patients may be reluctant to disclose to their physicians that they are currently smoking, leading to inaccurate reporting of exposure and missed opportunities to deliver smoking-cessation advice and treatment in the context of cancer care. We examined the extent of misclassification of recent smoking exposure among patients undergoing BCa surveillance. A consecutive sample of 145 patients with a self-reported smoking history and prior initial diagnosis of BCa was recruited from a tertiary referral urology clinic. Patients were asked if they had smoked a cigarette or used nicotine replacement therapy (NRT) within the past week and whether they lived with a smoker. At the same visit, we collected urine under a biospecimen protocol. We used urinary cotinine, the primary metabolite of nicotine, as an objective biomarker of recent smoking exposure. Nine patients whose urine could not be interpreted for cotinine were excluded. We calculated the smoking status misreporting rate by comparing biochemically verified smoking status (≥31.5 ng/ml vs &lt;31.5 ng/ml) against self-reported current smoking status (yes vs no) while considering recent NRT use. Overall, 11% (15 of 136) of patients had cotinine values consistent with current smoking. Of these 15 patients, 7 reported being former smokers, resulting in a 47% misclassification rate. However, three of the seven patients who denied smoking in the past week were currently using NRT. Excluding NRT users, the misclassification rate was 33%. Future studies investigating the impact of postdiagnosis nicotine exposure on BCa outcomes should use biochemical verification combined with self-reported smoking exposure to classify patients accurately. Bladder cancer patients may misreport smoking exposure, thereby missing opportunities for smoking cessation.</description><identifier>EISSN: 2405-4569</identifier><identifier>DOI: 10.1016/j.euf.2015.12.002</identifier><identifier>PMID: 28723477</identifier><language>eng</language><publisher>Netherlands</publisher><ispartof>European urology focus, 2016-10, Vol.2 (4), p.441</ispartof><rights>Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28723477$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thong, Alan E</creatorcontrib><creatorcontrib>Petruzella, Stacey</creatorcontrib><creatorcontrib>Orlow, Irene</creatorcontrib><creatorcontrib>Zabor, Emily C</creatorcontrib><creatorcontrib>Ehdaie, Behfar</creatorcontrib><creatorcontrib>Ostroff, Jamie S</creatorcontrib><creatorcontrib>Bochner, Bernard H</creatorcontrib><creatorcontrib>Furberg Barnes, Helena</creatorcontrib><title>Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center</title><title>European urology focus</title><addtitle>Eur Urol Focus</addtitle><description>Smoking is a risk factor for developing bladder cancer (BCa). Even though continued exposure after diagnosis may adversely affect prognosis, patients may be reluctant to disclose to their physicians that they are currently smoking, leading to inaccurate reporting of exposure and missed opportunities to deliver smoking-cessation advice and treatment in the context of cancer care. We examined the extent of misclassification of recent smoking exposure among patients undergoing BCa surveillance. A consecutive sample of 145 patients with a self-reported smoking history and prior initial diagnosis of BCa was recruited from a tertiary referral urology clinic. Patients were asked if they had smoked a cigarette or used nicotine replacement therapy (NRT) within the past week and whether they lived with a smoker. At the same visit, we collected urine under a biospecimen protocol. We used urinary cotinine, the primary metabolite of nicotine, as an objective biomarker of recent smoking exposure. Nine patients whose urine could not be interpreted for cotinine were excluded. We calculated the smoking status misreporting rate by comparing biochemically verified smoking status (≥31.5 ng/ml vs &lt;31.5 ng/ml) against self-reported current smoking status (yes vs no) while considering recent NRT use. Overall, 11% (15 of 136) of patients had cotinine values consistent with current smoking. Of these 15 patients, 7 reported being former smokers, resulting in a 47% misclassification rate. However, three of the seven patients who denied smoking in the past week were currently using NRT. Excluding NRT users, the misclassification rate was 33%. Future studies investigating the impact of postdiagnosis nicotine exposure on BCa outcomes should use biochemical verification combined with self-reported smoking exposure to classify patients accurately. Bladder cancer patients may misreport smoking exposure, thereby missing opportunities for smoking cessation.</description><issn>2405-4569</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFjr1OwzAUhS0k1FbQB-iC7gvE2E7SlLFERYyIlLkyyXXl4sTRjY3owrPjSjAzHZ2fTzqMraTgUsj1_YljNFwJWXKpuBDqii1UIcqsKNcPc7acppMQqS2qfJPP2FxtKpUXVbVg39u2jaTbM3gDDTqTEY6eAnbQ9P7DDkfYfY1-ioSw7X2yj053HRLUemiTvOhgcQgTvA0pPfoL0UT6ROvcZQE6gIY9UrCazvCKBom0gzpBSLfs2mg34fJXb9jd025fP2djfO-xO4xk-4Qd_g7n_w5-AMOWU6k</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Thong, Alan E</creator><creator>Petruzella, Stacey</creator><creator>Orlow, Irene</creator><creator>Zabor, Emily C</creator><creator>Ehdaie, Behfar</creator><creator>Ostroff, Jamie S</creator><creator>Bochner, Bernard H</creator><creator>Furberg Barnes, Helena</creator><scope>NPM</scope></search><sort><creationdate>201610</creationdate><title>Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center</title><author>Thong, Alan E ; Petruzella, Stacey ; Orlow, Irene ; Zabor, Emily C ; Ehdaie, Behfar ; Ostroff, Jamie S ; Bochner, Bernard H ; Furberg Barnes, Helena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_287234773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thong, Alan E</creatorcontrib><creatorcontrib>Petruzella, Stacey</creatorcontrib><creatorcontrib>Orlow, Irene</creatorcontrib><creatorcontrib>Zabor, Emily C</creatorcontrib><creatorcontrib>Ehdaie, Behfar</creatorcontrib><creatorcontrib>Ostroff, Jamie S</creatorcontrib><creatorcontrib>Bochner, Bernard H</creatorcontrib><creatorcontrib>Furberg Barnes, Helena</creatorcontrib><collection>PubMed</collection><jtitle>European urology focus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thong, Alan E</au><au>Petruzella, Stacey</au><au>Orlow, Irene</au><au>Zabor, Emily C</au><au>Ehdaie, Behfar</au><au>Ostroff, Jamie S</au><au>Bochner, Bernard H</au><au>Furberg Barnes, Helena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center</atitle><jtitle>European urology focus</jtitle><addtitle>Eur Urol Focus</addtitle><date>2016-10</date><risdate>2016</risdate><volume>2</volume><issue>4</issue><spage>441</spage><pages>441-</pages><eissn>2405-4569</eissn><abstract>Smoking is a risk factor for developing bladder cancer (BCa). Even though continued exposure after diagnosis may adversely affect prognosis, patients may be reluctant to disclose to their physicians that they are currently smoking, leading to inaccurate reporting of exposure and missed opportunities to deliver smoking-cessation advice and treatment in the context of cancer care. We examined the extent of misclassification of recent smoking exposure among patients undergoing BCa surveillance. A consecutive sample of 145 patients with a self-reported smoking history and prior initial diagnosis of BCa was recruited from a tertiary referral urology clinic. Patients were asked if they had smoked a cigarette or used nicotine replacement therapy (NRT) within the past week and whether they lived with a smoker. At the same visit, we collected urine under a biospecimen protocol. We used urinary cotinine, the primary metabolite of nicotine, as an objective biomarker of recent smoking exposure. Nine patients whose urine could not be interpreted for cotinine were excluded. We calculated the smoking status misreporting rate by comparing biochemically verified smoking status (≥31.5 ng/ml vs &lt;31.5 ng/ml) against self-reported current smoking status (yes vs no) while considering recent NRT use. Overall, 11% (15 of 136) of patients had cotinine values consistent with current smoking. Of these 15 patients, 7 reported being former smokers, resulting in a 47% misclassification rate. However, three of the seven patients who denied smoking in the past week were currently using NRT. Excluding NRT users, the misclassification rate was 33%. Future studies investigating the impact of postdiagnosis nicotine exposure on BCa outcomes should use biochemical verification combined with self-reported smoking exposure to classify patients accurately. Bladder cancer patients may misreport smoking exposure, thereby missing opportunities for smoking cessation.</abstract><cop>Netherlands</cop><pmid>28723477</pmid><doi>10.1016/j.euf.2015.12.002</doi></addata></record>
fulltext fulltext
identifier EISSN: 2405-4569
ispartof European urology focus, 2016-10, Vol.2 (4), p.441
issn 2405-4569
language eng
recordid cdi_pubmed_primary_28723477
source ScienceDirect Journals
title Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A06%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accuracy%20of%20Self-reported%20Smoking%20Exposure%20Among%20Bladder%20Cancer%20Patients%20Undergoing%20Surveillance%20at%20a%20Tertiary%20Referral%20Center&rft.jtitle=European%20urology%20focus&rft.au=Thong,%20Alan%20E&rft.date=2016-10&rft.volume=2&rft.issue=4&rft.spage=441&rft.pages=441-&rft.eissn=2405-4569&rft_id=info:doi/10.1016/j.euf.2015.12.002&rft_dat=%3Cpubmed%3E28723477%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-pubmed_primary_287234773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28723477&rfr_iscdi=true